DK1648440T3 - Halvfaste formuleringer til den orale indgivelse af taxoider - Google Patents

Halvfaste formuleringer til den orale indgivelse af taxoider

Info

Publication number
DK1648440T3
DK1648440T3 DK04741331T DK04741331T DK1648440T3 DK 1648440 T3 DK1648440 T3 DK 1648440T3 DK 04741331 T DK04741331 T DK 04741331T DK 04741331 T DK04741331 T DK 04741331T DK 1648440 T3 DK1648440 T3 DK 1648440T3
Authority
DK
Denmark
Prior art keywords
taxoids
semi
oral administration
solid formulations
formulations
Prior art date
Application number
DK04741331T
Other languages
English (en)
Inventor
Tatiana Borovac
Carole Neves
Maria-Teresa Peracchia
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1648440T3 publication Critical patent/DK1648440T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK04741331T 2003-07-18 2004-07-15 Halvfaste formuleringer til den orale indgivelse af taxoider DK1648440T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291795A EP1498120A1 (en) 2003-07-18 2003-07-18 Semi-solid formulations for the oral administration of taxoids
PCT/EP2004/008551 WO2005013968A1 (en) 2003-07-18 2004-07-15 Semi-solid formulations for the oral administration of taxoids

Publications (1)

Publication Number Publication Date
DK1648440T3 true DK1648440T3 (da) 2008-07-14

Family

ID=33462258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04741331T DK1648440T3 (da) 2003-07-18 2004-07-15 Halvfaste formuleringer til den orale indgivelse af taxoider

Country Status (21)

Country Link
US (1) US20050070496A1 (da)
EP (2) EP1498120A1 (da)
JP (1) JP5116306B2 (da)
KR (1) KR101143341B1 (da)
CN (1) CN1826110B (da)
AR (1) AR045996A1 (da)
AT (1) ATE388701T1 (da)
AU (1) AU2004262496B2 (da)
BR (1) BRPI0412759A (da)
CA (1) CA2532667A1 (da)
DE (1) DE602004012413T2 (da)
DK (1) DK1648440T3 (da)
ES (1) ES2303642T3 (da)
HK (1) HK1091743A1 (da)
IL (1) IL173110A (da)
IN (1) IN229997B (da)
MX (1) MX260260B (da)
MY (1) MY137965A (da)
PT (1) PT1648440E (da)
TW (1) TWI342774B (da)
WO (1) WO2005013968A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498143A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
WO2007139930A2 (en) * 2006-05-26 2007-12-06 Bayer Healthcare Llc Drug combinations with substituted diaryl ureas for the treatment of cancer
FR2922107B1 (fr) * 2007-10-10 2010-02-26 Aventis Pharma Sa Nouvelles compositions a base de taxoides
FR2924024B1 (fr) 2007-11-27 2012-08-17 Centre Nat Rech Scient Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse
FR2931152B1 (fr) * 2008-05-16 2010-07-30 Centre Nat Rech Scient Nouveau systeme de transfert d'acide nucleique
MY164086A (en) 2009-10-29 2017-11-30 Aventis Pharma Sa Novel antitumoral use of cabazitaxel
CA2798180A1 (en) 2010-05-03 2011-11-10 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN103980232A (zh) * 2014-06-05 2014-08-13 北京诺普德医药科技有限公司 10-乙酰基多西紫杉醇及其用途
KR101542364B1 (ko) * 2014-10-31 2015-08-07 대화제약 주식회사 탁산을 포함하는 경구 투여용 약학 조성물
CN113698369A (zh) * 2021-08-31 2021-11-26 无锡紫杉药业有限公司 一种除去卡巴他赛中特定单杂的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
JP3208517B2 (ja) * 1992-07-01 2001-09-17 ブリストル−マイヤーズ スクイブ カンパニー ７，８−シクロプロパタキサン類
US5478854A (en) * 1992-10-01 1995-12-26 Bristol-Myers Squibb Company Deoxy taxols
US5973160A (en) * 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US5646176A (en) * 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes
WO1999049848A1 (en) * 1998-04-01 1999-10-07 Rtp Pharma Inc. Anticancer compositions
CA2373994A1 (en) * 1999-05-24 2000-11-30 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
EP1365759A2 (en) * 2001-01-18 2003-12-03 PHARMACIA & UPJOHN COMPANY Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
US20040092428A1 (en) * 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
BR0215184A (pt) * 2001-12-20 2006-06-06 Bristol Myers Squibb Co composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
WO2003074027A2 (en) * 2002-03-01 2003-09-12 Novagali Pharma Sa Self emulsifying drug delivery systems for poorly soluble drugs
KR20090072980A (ko) * 2007-12-28 2009-07-02 서울옵토디바이스주식회사 발광 다이오드 및 그 제조방법

Also Published As

Publication number Publication date
DE602004012413D1 (de) 2008-04-24
KR20060037370A (ko) 2006-05-03
AU2004262496B2 (en) 2009-02-05
PT1648440E (pt) 2008-06-24
CN1826110A (zh) 2006-08-30
IN229997B (da) 2009-03-27
MY137965A (en) 2009-04-30
CN1826110B (zh) 2010-05-12
IL173110A0 (en) 2006-06-11
AR045996A1 (es) 2005-11-23
US20050070496A1 (en) 2005-03-31
ATE388701T1 (de) 2008-03-15
AU2004262496A1 (en) 2005-02-17
KR101143341B1 (ko) 2012-05-24
IL173110A (en) 2011-04-28
EP1648440A1 (en) 2006-04-26
JP5116306B2 (ja) 2013-01-09
ES2303642T3 (es) 2008-08-16
TWI342774B (en) 2011-06-01
MXPA06000636A (es) 2006-04-19
JP2009513558A (ja) 2009-04-02
CA2532667A1 (en) 2005-02-17
TW200517104A (en) 2005-06-01
WO2005013968A1 (en) 2005-02-17
BRPI0412759A (pt) 2006-09-26
HK1091743A1 (en) 2007-01-26
DE602004012413T2 (de) 2009-03-12
EP1498120A1 (en) 2005-01-19
MX260260B (es) 2008-09-04
EP1648440B1 (en) 2008-03-12
IN2006CH00198A (da) 2007-06-08

Similar Documents

Publication Publication Date Title
DK1592457T3 (da) Folat-vinblastin-konjugat som lægemiddel
DK1601359T3 (da) Væskeformige, farmaceutiske formuleringer af palonosetron
DK3395338T3 (da) Hurtigt opløsende formulering af cinacalcet-hcl
DK1490037T3 (da) Smagsmaskeret faste sammensætninger af veterinærmedicin
PT1501534E (pt) Formulacoes farmaceuticas
IS8309A (is) Lyfjablöndur
DK1599186T3 (da) System til administration af transmukalt lægemiddel
DK1448235T3 (da) Orale, farmaceutiske sammensætninger af 5,8,14-triaza-tetracyclo[10.3.1.0(2,11).0(4.9)]-hexadeca-2(11),3,5,7,9-pentaen med kontrolleret frigivelse
HK1091743A1 (en) Semi-solid formulations for the oral administration of taxoids
MX266708B (es) Formulaciones de microparticulas de pantoprazol.
DE60109207D1 (de) Orale zusammensetzung
DK1353668T3 (da) Fremgangsmåder til fremstillingen af farmaceutiske sammensætninger, der indeholder epothilonanaloger, til behandlingen af cancer
DK1830785T3 (da) Orale sammensætninger indeholdende oxideret Camellia
DK1837019T3 (da) Orale dispergerbare farmaceutiske sammensætninger
DK1450606T3 (da) Synergistiske sammensætninger til behandling af såsæd
SE0302061L (sv) Tandsystem
IS7481A (is) Epóthílon til gjafar um munn
NO20043937L (no) Anvendelse av vitamin D sammensetninger
DK1458413T3 (da) Farmaceutiske sammensætninger på b asis af azetidin-derivater
DE60326998D1 (de) Orale zubereitung
DK1608344T3 (da) Orale cladribin-formuleringer
ITRM20030074A0 (it) Formulazioni semisolide a rilascio immediato intese per la somministrazione orale di farmaci.
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
FR2854072B1 (fr) Vecteur pour administration par voie orale
DK1646373T3 (da) Orodispergerbar farmaceutisk sammensætning af en antithrombotisk forbindelse